China's SFDA Ready to Fast-Track Approvals of Peramivir, a Flu Treatment

Published: Apr 09, 2013

by Richard Daverman, PhD

April 8, 2013 -- In the wake of the growing bird flu outbreak, China’s SFDA will fast-track approvals of a flu treatment – not a vaccine – known as peramivir (peramivir sodium chloride injection). The drug is a neuraminidase inhibitor, which works by preventing the virus from moving from an infected cell to infect other cells. Guangzhou Nanxin Pharma has been approved to produce the medicine, and it expects to begin distributing the drug in 30 days. Other China pharmas have also filed for approval to make the drug or conduct human clinical trials. More details....

Back to news